Advaxis, Inc. (ADXS) Presenting at the Bloomberg 2014 State of Healthcare Summit

Advaxis today reported that its Chief Scientific Officer, Robert G. Petit, Ph.D. will be presenting on an expert panel entitled “”The Future of Cancer Immunotherapy” during the Bloomberg 2014 State of Healthcare Summit. The summit will be taking place Friday, February 14, 2014 at 11:15 am EST at Bloomberg’s offices at 731 Lexington Avenue, New York, NY 10022.

This year, the summit will feature panels of thought leaders and experts in oncology drug development and healthcare policy, as well as other key stakeholders in pharmaceuticals and biotech. These panels will be focusing their discussions on major issues developing or burgeoning within the pharmaceutical, biotech, and device industries in 2014. The panel discussions will be moderated by Bloomberg healthcare experts and will also feature Q&A sessions.

Advaxis is a clinical-stage biotechnology company developing the next generation of cancer immunotherapies. Advaxis’ immunotherapies are based on a novel platform technology using live, attenuated bacteria to stimulate the immune system to selectively target cancer cells while reducing tumor defenses.

For more information about Advaxis and its initiatives, visit: http://www.advaxis.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html